Inventor · disambiguated record
Andrew C. Good
Also filed as: GOOD ANDREW · GOOD ANDREW C · GOOD ANDREW CHARLES
70 granted patents·28 pending applications·1,745 citations·filing 2001–2025
99Inventor score
Files withBRISTOL MYERS SQUIBB CO27GENENTECH INC12C4 THERAPEUTICS INC10GENZYME CORP9BIAL R&D INVEST S A8
Top patents by PatentIndex Score
98 records- 0198US7741347B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 22, 2010·52 cites·13 claims
- 0298US7449479B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 11, 2008·67 cites·16 claims
- 0398US6995174B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 7, 2006·194 cites·48 claims
- 0497US11407732B1Tricyclic degraders of Ikaros and AiolosC4 THERAPEUTICS INC·Filed 2021·Granted Aug 9, 2022·10 cites·30 claims
- 0597US8303944B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2008·Granted Nov 6, 2012·36 cites·13 claims
- 0697US7704992B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 27, 2010·58 cites·25 claims
- 0797US7659270B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Feb 9, 2010·72 cites·25 claims
- 0897US7323447B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 29, 2008·50 cites·26 claims
- 0997US6869964B2Heterocyclicsulfonamide hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Mar 22, 2005·134 cites·32 claims
- 1097US6867185B2Inhibitors of hepatitis C virusBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Mar 15, 2005·153 cites·14 claims
- 1196US11091492B2Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Aug 17, 2021·5 cites·38 claims
- 1296US10786508B2Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2018·Granted Sep 29, 2020·10 cites·30 claims
- 1396US10751341B2Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·12 cites·35 claims
- 1496US7906655B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Mar 15, 2011·37 cites·28 claims
- 1596US7759495B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jul 20, 2010·41 cites·31 claims
- 1696US7745636B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 29, 2010·53 cites·26 claims
- 1796US7041698B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 9, 2006·135 cites·19 claims
- 1896US6872805B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 29, 2005·153 cites·33 claims
- 1995US11932645B2Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2021·Granted Mar 19, 2024·2 cites·20 claims
- 2095US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 2195US8574563B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2012·Granted Nov 5, 2013·18 cites·26 claims
- 2295US7173004B2Macrocyclic isoquinoline peptide inhibitors of hepatitis C virusBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 6, 2007·90 cites·44 claims
- 2395US6878722B2Substituted cycloalkyl P1′ hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Apr 12, 2005·134 cites·31 claims
- 2494US11351173B2Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Jun 7, 2022·3 cites·19 claims
- 2594US10570135B2Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2015·Granted Feb 25, 2020·13 cites·18 claims
- 2693US11807644B2Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2021·Granted Nov 7, 2023·3 cites·21 claims
- 2792US11400095B2Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Aug 2, 2022·2 cites·16 claims
- 2892US11008316B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted May 18, 2021·6 cites·2 claims
- 2992US8846023B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 30, 2014·7 cites·13 claims
- 3092US8642025B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Feb 4, 2014·12 cites·40 claims
- 3192US7741281B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 22, 2010·20 cites·19 claims
- 3291US10787454B2Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL BIOTECH INVEST INC·Filed 2017·Granted Sep 29, 2020·10 cites·24 claims
- 3391US8147818B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2009·Granted Apr 3, 2012·22 cites·22 claims
- 3490US11814373B2Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2020·Granted Nov 14, 2023·2 cites·16 claims
- 3590US11453675B2Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Sep 27, 2022·2 cites·18 claims
- 3690US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 3790US7309708B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Dec 18, 2007·39 cites·27 claims
- 3889US8492553B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2012·Granted Jul 23, 2013·11 cites·31 claims
- 3988US9227961B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 5, 2016·6 cites·12 claims
- 4087US10308614B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jun 4, 2019·4 cites·21 claims
- 4187US9493510B2Peptidomimetic compoundsNOLIVA THERAPEUTICS LLC·Filed 2014·Granted Nov 15, 2016·7 cites·11 claims
- 4287US8288562B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2010·Granted Oct 16, 2012·9 cites·31 claims
- 4386US12060349B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Granted Aug 13, 2024·1 cites·7 claims
- 4486US11192892B2Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disordersBIAL—BIOTECH INVEST INC·Filed 2017·Granted Dec 7, 2021·4 cites·18 claims
- 4586US7902218B2Substituted tetrahydroisoquinolines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 8, 2011·5 cites·7 claims
- 4686US2025066364A1Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disordersBIAL R&D INVEST S A·Filed 2024·Application pending·0 cites
- 4783US11124516B2Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL—BIOTECH INVEST INC·Filed 2017·Granted Sep 21, 2021·4 cites·16 claims
- 4883US9018390B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 28, 2015·4 cites·31 claims
- 4983US7338974B2Macrocyclic diaminopropanes as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 4, 2008·6 cites·8 claims
- 5082US12428406B2Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2023·Granted Sep 30, 2025·0 cites·20 claims
Showing the top 50 of 98 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →